ADC Therapeutics
ZYNLONTA
Manufacturer:
ADC Therapeutics
Name:
ZYNLONTA
Category:
J Code
HCPCS:
J9359
NDC(s):
79952-0110-01,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
ZYNLONTA is a Cancer drug manufactured by ADC Therapeutics and administered via the Intravenous route of administration. The J Code: J9359 is aligned to the drug ZYNLONTA.